Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain

Transplantation

Volumn 63, Issue 9, 1997, Pages 1278-1286

  Aguado, Jose M ^a,f   Herrero, Jose A ^a   Gavaldá, Joan ^b   Torre Cisneros, Julian ^d   Blanes, Marino ^e   Rufí, Gabriel ^c,g   Moreno, Asunción ^c   Gurguí, Mercè ^c,h   Hayek, Marcelino ^a   Lumbreras, Carlos ^a   Morales, J M ^a   Pahissa, A ^b   Margerit, C ^b   Prada, J L ^d   Kindelan J M ^d   Ros, F ^e   Pallardo L M ^e   Carratala J ^g   Gudiol, F ^g   Gonzalez J ^c   Vilardell, J ^c   Guirado, L ^h   Rabella, N ^h   more..

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f Hospital Reina Sofía ^*  (Spain)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^h HOSPITAL SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; ETHAMBUTOL; ISONIAZID; LYMPHOCYTE ANTIBODY; OKT 3; PYRAZINAMIDE; RIFAMPICIN; STEROID; STREPTOMYCIN; THYMOCYTE ANTIBODY; TUBERCULIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; LIVER TOXICITY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; SKIN TOXICITY; SPAIN; TREATMENT OUTCOME; TUBERCULOSIS;

ADULT; AGED; ANTITUBERCULAR AGENTS; FEMALE; HEART TRANSPLANTATION; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 0030984817     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199705150-00015     Document Type: Article

References (56)

1. Miller RA, Lanza, LA, Kline JN, Geist LJ. Mycobacterium tuberculosis in lung transplant recipients. Am J Respir Crit Care Med 1995; 152: 374.
2. Roberts G, Koneman E, Yoo KM. Mycobacterium. In: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ, eds. Manual of clinical microbiology, 5th ed. Washington, DC: American Society for Microbiology, 1991: 304.
3. Lloveras J, Phillip K, Peterson R, Simmons RL, Najarian JS. Mycobacterial infections in renal transplant recipients. Arch Intern Med 1982; 142: 888.
4. Qunibi WY, Al-Sibai MB, Taher S, et al. Mycobacterial infection after renal transplantation: report of 14 cases and review of the literature. Q J Med 1990; 77: 1039.
5. Higgins RM, Cahn AP, Porter D, et al. Mycobacterial infections after renal transplantation. Q J Med 1991; 78: 145.
6. Koselj M, Buturovic J, Malovrth M. Tuberculosis in renal allograft recipients. Transplant Proc 1992; 24: 1909.
7. Riska H, Grönhagen-Riska C, Ahonen J. Tuberculosis and renal allograft transplantation. Transplant Proc 1987; 19: 4096.
8. Higgins RSD, Kusne S, Reyes J, et al. Mycobacterium tuberculosis after liver transplantation: management and guidelines for prevention. Clin Transplant 1992; 6: 81.
9. Delaney V, Sumrani N, Hong JH, Sommer B. Mycobacterial infections in renal allograft recipients. Transplant Proc 1993; 25: 2288.
10. Hall CM, Willcox PA, Swanepoel CR, Kahn D, Van Zyl-Smit R. Mycobacterial infection in renal transplant recipients. Chest 1994; 106: 435.
11. John GT, Vincent L, Jeyaseelan L, Jacob CK, Shastry JCM. Cyclosporine immunosuppression and mycobacterial infections. Transplantation 1994; 58: 247.
12. Stöblen F, Neuhaus R, Neumann K, et al. Tuberculosis in liver transplant recipients: recurrence after transplantation? Transplant Proc 1994; 26: 3604.
13. Wong LL, Levin BS, Collins GM, Bry WI. Unusual manifestations of tuberculosis in cyclosporine-treated renal transplant recipients. Clin Transplant 1993; 7: 18.
14. De March P. Situación actual de la tuberculosis en España. Med Clín 1991; 97: 463.
15. Vidal R, Garcia J, Ruiz J, Fite E, Monsó E, Martín N. Estudio controlado de 637 pacientes con tuberculosis: diagnóstico y resultados terapéuticos con esquemas de 9 y 6 meses. Med Clín 1986; 87: 368.
16. De March P. Tuberculosis y SIDA: situación en España y perspectivas. Rev Clín Esp 1990; 186: 365.
17. Rey R, Ausina V, Casal M, et al. Situación actual de la tuberculosis en España: una perspectiva sanitaria en precario respecto a los países desarrollados. Med Clín 1995; 105: 703.
18. Garcia-Leoni ME, Martin-Scapa C, Rodeño P, Valderrábano F, Moreno S, Bouza E. High incidence of tuberculosis in renal patients. Eur J Clin Microbiol Infect Dis 1990; 9: 283.
19. Muñoz P, Palomo J, Muñoz R, Rodríguez-Creixéms M, Peláez T, Bouza E. Tuberculosis in heart transplant recipients. Clin Infect Dis 1995; 21: 398.
20. Coutts IJ, Jegarajah S, Stark JE. Tuberculosis in renal transplant recipients. Br J Dis Chest 1979; 73: 141.
21. Riska H, Kuhlback B. Tuberculosis and kidney transplantation. Acta Med Scand 1979; 205: 637.
22. Neff TA, Hudgel DW. Miliary tuberculosis in a renal transplant recipient. Am Rev Respir Dis 1973; 108: 677.
23. Sinnott JT, Emmanuel PJ. Mycobacterial infections in the transplant patient. Semin Respir Infect 1990; 5: 65.
24. Delaney V, Sumrani N, Hong JH, Sommer B. Mycobacterial infections in renal allograft recipients. Transplant Proc 1993; 25: 2288.
25. Lichtenstein IH, MacGregor RR. Mycobacterial infections in renal transplant recipients: report of five cases and review of the literature. Rev Infect Dis 1983; 5: 216.
26. McWhinney N, Khan O, Williams G. Tuberculosis in patients undergoing maintenance haemodialysis and renal transplantation. Br J Surg 1981; 68: 408.
27. Malhotra KK, Dash SC, Dhawan IK, Bhuyan UN, Gupta A. Tuberculosis and renal transplantation: observations from an endemic area of tuberculosis. Postgrad Med J 1986; 62: 359.
28. Naqvi SA, Hussain M, Askari H, et al. Is there a place for prophylaxis against tuberculosis following renal transplantation? Transplant Proc 1992; 24: 1912.
29. Dromer C, Nashef SAM, Velly JF, Martigne C, Couraud L. Tuberculosis in transplanted lungs. J Heart Lung Transplant 1993; 12: 924.
30. Jereb JA, Burwen DR, Dooley SW, Haas WH, Crawford JT, Geiter LJ. Nosocomial outbreak of tuberculosis in a renal transplant unit: application of a new technique for restriction fragment polymorphism analysis of Mycobacterium tuberculosis isolates. J Infect Dis 1993; 168: 1219.
31. Costa JMN, Meyers AM, Botha JR, Conlan AA, Myburgh A. Mycobacterial infections in recipients of kidney allografts: a seventeen-year experience. Acta Med Port 1988; 1: 51.
32. Torre-Cisneros J, De la Mata M, Rufian S, et al. Importance of surveillance mycobacterial cultures after liver transplantation. Transplantation 1995; 60: 1054.
33. Sundberg R, Shapiro R, Darras F, et al. A tuberculosis outbreak in a renal transplant program. Transplant Proc 1991; 23: 3091.
34. Langhoff E, Madsen S. Rapid metabolism of cyclosporin and prednisone in kidney transplant patient receiving tuberculostatic treatment [Letter]. Lancet 1983; 2: 1031.
35. Cassidy MJD, Van Zyl-Smit R, Pascoe MD, Swanepoel CR, Jacobson JE. Effect of rifampicin on cyclosporin A blood levels in a renal transplant recipient [Letter]. Nephron 1985; 41: 207.
36. Offermann G, Keller F, Molzahn M. Low cyclosporine A bloods level and acute graft rejection in a renal transplant recipient during rifampin treatment. Am J Nephrol 1985; 5: 385.
37. Buffington GA, Dominguez JH, Piering WF, Hebert LA, Kauffman HM Jr, Lemann J Jr. Interaction of rifampicin and glucocorticoids: adverse effect on renal allograft function. JAMA 1976; 236: 1958.
38. Modry DL, Stinson EB, Oyer PE, Jamieson SW, Baldwin JC, Shumway NE. Acute rejection and massive cyclosporine requirements in heart transplant recipients treated with rifampin. Transplantation 1985; 39: 313.
39. Chan GL, Sinnott JT, Emmanuel PJ, Cyanle S, Weinstein SS. Drug interactions with cyclosporine: focus on antimicrobial agents. Clin Transplant 1992; 6: 141.
40. Daniels NJ, Dover JS, Schachter RK. Interaction between cyclosporin and rifampin [Letter]. Lancet 1984; 2: 639.
41. Al-Sulaiman MH, Dhar JM, Al-Khader AA. Successful use of rifampin in the treatment of tuberculosis in renal transplant patients immunosuppressed with cyclosporine. Transplantation 1990; 50: 597.
42. Ettinger NA, Trulock EP. Pulmonary considerations of organ transplantation. Am Rev Respir Dis 1991; 143: 1386.
43. Abbott MR, Smith DD. Mycobacterial infections in immunosuppressed patient. South Med J Aust 1981; 1: 351.
44. American Thoracic Society. Medical Section of the American Lung Association: treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986; 134: 355.
45. Al Batata M. Pulmonary tuberculosis in a renal transplant recipient. JAMA 1977; 237: 1465.
46. Thomas PA Jr, Mozes MF, Jonasson O. Hepatic dysfunction during isoniazid chemoprophylaxis in renal allograft recipients. Arch Surg 1979; 114: 597.
47. American Thoracic Society. Preventive therapy of tuberculous infection. Am Rev Respir Dis 1974; 110: 371.
48. John GT, Thomas PP, Thomas M, Jeyaseelan L, Jacob CK, Shastry JCM. A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients. Transplantation 1994; 57: 1683.
49. Thomas PA, Manko MA. Chemoprophylaxis for the prevention of the tuberculosis in the immunosuppressed renal allograft recipient. Transplantation 1975; 20: 76.
50. Meyers BR, Halpern M, Sheiner P, Mendelson MH, Neibart E, Miller C. Tuberculosis in liver transplant patients. Transplantation 1994; 58: 301.
51. Mullerova M, Pekarek J, Nouzak J. Immunosuppression and experimental tuberculosis. Biomedicine 1974; 20: 390.
52. Gottesdiener KM. Transplanted infections: donor-to-host transmission with the allograft. Ann Intern Med 1989; 110: 1001.
53. Moreno S, Baraia-Etxaburu J, Bouza E, et al. Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med 1993; 119: 194.
54. Kusne S, Irish W, Geary K, Ondick L, Rakela J, Fung J. Anergy panel and purified protein derivative skin testing are poor tuberculosis screening methods in adult liver candidates [Abstract J33]. In: Program and abstracts: 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco: American Society for Microbiology, 1995: 262.
55. Passannante MR, Restifo RA, Reichman LB. Preventive therapy for the patient with both universal indication and contraindication for isoniazid. Chest 1993; 103: 825.
56. Sakhuja V, Jha V, Varma PP, Joshi K, Chugh KS. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996; 61: 211.